title: How should myocardial viability be assessed by 18F-fluoro-2-deoxyglucose positron emission tomography?
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Momose
mesh_terms: D005227:Fatty Acids / Q000008:administration & dosage*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage*; D006801:Humans; D007462:Iodobenzenes / Q000008:administration & dosage*; D008297:Male; D009203:Myocardial Infarction / Q000000981:diagnostic imaging*; D062645:Percutaneous Coronary Intervention; D049268:Positron-Emission Tomography; D011859:Radiography; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D005227:Fatty Acids; D007462:Iodobenzenes; D019275:Radiopharmaceuticals; C049338:iodofiltic acid; D019788:Fluorodeoxyglucose F18